微嵌合检测用indel面板的研制

IF 2.8 4区 医学 Q2 PATHOLOGY
Sofie D.H. Olsen , Astrid M. Kolte , Nina Bang , Maria Christine Krog , Rudi Steffensen , Henriette S. Nielsen , Marianne A. Jakobsen
{"title":"微嵌合检测用indel面板的研制","authors":"Sofie D.H. Olsen ,&nbsp;Astrid M. Kolte ,&nbsp;Nina Bang ,&nbsp;Maria Christine Krog ,&nbsp;Rudi Steffensen ,&nbsp;Henriette S. Nielsen ,&nbsp;Marianne A. Jakobsen","doi":"10.1016/j.yexmp.2022.104804","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>The aim of the study was to create a simple assay for microchimerism detection independent of sex and without HLA genotyping.</p></div><div><h3>Methods</h3><p><span><span>The method is based on detection of insertion or deletions utilizing a multiplex PCR followed by fragment analysis by </span>capillary electrophoresis, and probe-based qPCR assays. A total of 192 samples, taken either before pregnancy, during 1st trimester, or either during </span>2nd trimester<span><span> or at miscarriage, obtained from a cohort of 97 female patients with either primary or secondary recurrent pregnancy loss, were screened for fetal microchimerism by the </span>indel panel as well as an existing assay based on detection of the Y-chromosome marker; DYS14.</span></p></div><div><h3>Results</h3><p><span>The overall prevalence of DYS14 positive samples was 29% (55/192) whereas 32% (61/192) tested positive by the indel method. There was an overall agreement of 64% (122/192) between the results obtained by the two methods. A Fisher's Exact test showed no statistic significant difference in the prevalence of microchimerism detected by the two methods at any of the three times of sampling. The distribution of the number of positive wells detected by both methods were compared by a Mann-Whitney </span><em>U</em> test, which showed no statistically significant difference at any of the three times of sampling.</p></div><div><h3>Conclusion</h3><p>The data indicates that microchimerism can be detected efficiently by the indel method. This makes it possible to detect both female and male cells without the need of HLA-genotyping. Furthermore, the indel method has potential to be implemented as a routine analysis. This will remove the sex bias in future explorations of the role microchimerism plays in health and disease.</p></div>","PeriodicalId":12176,"journal":{"name":"Experimental and molecular pathology","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The development of an indel panel for microchimerism detection\",\"authors\":\"Sofie D.H. Olsen ,&nbsp;Astrid M. Kolte ,&nbsp;Nina Bang ,&nbsp;Maria Christine Krog ,&nbsp;Rudi Steffensen ,&nbsp;Henriette S. Nielsen ,&nbsp;Marianne A. Jakobsen\",\"doi\":\"10.1016/j.yexmp.2022.104804\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><p>The aim of the study was to create a simple assay for microchimerism detection independent of sex and without HLA genotyping.</p></div><div><h3>Methods</h3><p><span><span>The method is based on detection of insertion or deletions utilizing a multiplex PCR followed by fragment analysis by </span>capillary electrophoresis, and probe-based qPCR assays. A total of 192 samples, taken either before pregnancy, during 1st trimester, or either during </span>2nd trimester<span><span> or at miscarriage, obtained from a cohort of 97 female patients with either primary or secondary recurrent pregnancy loss, were screened for fetal microchimerism by the </span>indel panel as well as an existing assay based on detection of the Y-chromosome marker; DYS14.</span></p></div><div><h3>Results</h3><p><span>The overall prevalence of DYS14 positive samples was 29% (55/192) whereas 32% (61/192) tested positive by the indel method. There was an overall agreement of 64% (122/192) between the results obtained by the two methods. A Fisher's Exact test showed no statistic significant difference in the prevalence of microchimerism detected by the two methods at any of the three times of sampling. The distribution of the number of positive wells detected by both methods were compared by a Mann-Whitney </span><em>U</em> test, which showed no statistically significant difference at any of the three times of sampling.</p></div><div><h3>Conclusion</h3><p>The data indicates that microchimerism can be detected efficiently by the indel method. This makes it possible to detect both female and male cells without the need of HLA-genotyping. Furthermore, the indel method has potential to be implemented as a routine analysis. This will remove the sex bias in future explorations of the role microchimerism plays in health and disease.</p></div>\",\"PeriodicalId\":12176,\"journal\":{\"name\":\"Experimental and molecular pathology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2022-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Experimental and molecular pathology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0014480022000673\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PATHOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and molecular pathology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0014480022000673","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的建立一种无需HLA基因分型,且与性别无关的微嵌合检测方法。方法采用多重PCR检测插入或缺失,然后进行毛细管电泳片段分析和探针qPCR分析。从97例原发或继发复发性妊娠丢失的女性患者中抽取的妊娠前、妊娠早期、妊娠中期或流产时共192个样本,通过indel panel和现有的基于y染色体标记检测的检测方法筛选胎儿微嵌合;DYS14。结果DYS14总阳性率为29%(55/192),而indel法检测阳性率为32%(61/192)。两种方法的结果一致度为64%(122/192)。Fisher精确检验显示,在三次抽样中,两种方法检测到的微嵌合的发生率没有统计学上的显著差异。通过Mann-Whitney U检验比较了两种方法检测到的阳性井的数量分布,在三次采样中,任何一次都没有统计学上的显著差异。结论indel方法可以有效地检测微嵌合现象。这使得不需要hla基因分型就可以检测女性和男性细胞。此外,indel方法有可能被实现为常规分析。这将消除未来探索微嵌合在健康和疾病中所起作用的性别偏见。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The development of an indel panel for microchimerism detection

Objectives

The aim of the study was to create a simple assay for microchimerism detection independent of sex and without HLA genotyping.

Methods

The method is based on detection of insertion or deletions utilizing a multiplex PCR followed by fragment analysis by capillary electrophoresis, and probe-based qPCR assays. A total of 192 samples, taken either before pregnancy, during 1st trimester, or either during 2nd trimester or at miscarriage, obtained from a cohort of 97 female patients with either primary or secondary recurrent pregnancy loss, were screened for fetal microchimerism by the indel panel as well as an existing assay based on detection of the Y-chromosome marker; DYS14.

Results

The overall prevalence of DYS14 positive samples was 29% (55/192) whereas 32% (61/192) tested positive by the indel method. There was an overall agreement of 64% (122/192) between the results obtained by the two methods. A Fisher's Exact test showed no statistic significant difference in the prevalence of microchimerism detected by the two methods at any of the three times of sampling. The distribution of the number of positive wells detected by both methods were compared by a Mann-Whitney U test, which showed no statistically significant difference at any of the three times of sampling.

Conclusion

The data indicates that microchimerism can be detected efficiently by the indel method. This makes it possible to detect both female and male cells without the need of HLA-genotyping. Furthermore, the indel method has potential to be implemented as a routine analysis. This will remove the sex bias in future explorations of the role microchimerism plays in health and disease.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
8.90
自引率
0.00%
发文量
78
审稿时长
11.5 weeks
期刊介绍: Under new editorial leadership, Experimental and Molecular Pathology presents original articles on disease processes in relation to structural and biochemical alterations in mammalian tissues and fluids and on the application of newer techniques of molecular biology to problems of pathology in humans and other animals. The journal also publishes selected interpretive synthesis reviews by bench level investigators working at the "cutting edge" of contemporary research in pathology. In addition, special thematic issues present original research reports that unravel some of Nature''s most jealously guarded secrets on the pathologic basis of disease. Research Areas include: Stem cells; Neoangiogenesis; Molecular diagnostics; Polymerase chain reaction; In situ hybridization; DNA sequencing; Cell receptors; Carcinogenesis; Pathobiology of neoplasia; Complex infectious diseases; Transplantation; Cytokines; Flow cytomeric analysis; Inflammation; Cellular injury; Immunology and hypersensitivity; Athersclerosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信